T. Rowe Price Associates’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$123K Buy
172,521
+1,243
+0.7% +$886 ﹤0.01% 2852
2025
Q1
$252K Buy
171,278
+75,380
+79% +$111K ﹤0.01% 2534
2024
Q4
$425K Sell
95,898
-7,458
-7% -$33.1K ﹤0.01% 2344
2024
Q3
$426K Buy
103,356
+1,908
+2% +$7.86K ﹤0.01% 2327
2024
Q2
$662K Buy
101,448
+15,871
+19% +$104K ﹤0.01% 2069
2024
Q1
$746K Buy
85,577
+4,993
+6% +$43.5K ﹤0.01% 2036
2023
Q4
$922K Buy
80,584
+8,477
+12% +$97K ﹤0.01% 1903
2023
Q3
$695K Buy
72,107
+10,762
+18% +$104K ﹤0.01% 1959
2023
Q2
$653K Buy
61,345
+1,551
+3% +$16.5K ﹤0.01% 2007
2023
Q1
$630K Sell
59,794
-32,901
-35% -$347K ﹤0.01% 2009
2022
Q4
$1.15M Sell
92,695
-7,694
-8% -$95.3K ﹤0.01% 1697
2022
Q3
$1.04M Buy
100,389
+8,992
+10% +$93.2K ﹤0.01% 1724
2022
Q2
$1.05M Sell
91,397
-153
-0.2% -$1.76K ﹤0.01% 1870
2022
Q1
$1.15M Sell
91,550
-6,067
-6% -$76.3K ﹤0.01% 1922
2021
Q4
$1.14M Sell
97,617
-24,528
-20% -$286K ﹤0.01% 1961
2021
Q3
$1.6M Sell
122,145
-10,700
-8% -$140K ﹤0.01% 1825
2021
Q2
$1.71M Sell
132,845
-18,069
-12% -$233K ﹤0.01% 1802
2021
Q1
$1.69M Sell
150,914
-22,160
-13% -$248K ﹤0.01% 1795
2020
Q4
$1.97M Sell
173,074
-787,084
-82% -$8.96M ﹤0.01% 1641
2020
Q3
$8.64M Sell
960,158
-64,134
-6% -$577K ﹤0.01% 1327
2020
Q2
$10.6M Sell
1,024,292
-201,831
-16% -$2.08M ﹤0.01% 1287
2020
Q1
$12.4M Buy
1,226,123
+59,308
+5% +$598K ﹤0.01% 1191
2019
Q4
$15.5M Sell
1,166,815
-4,067
-0.3% -$54.1K ﹤0.01% 1237
2019
Q3
$10.1M Buy
1,170,882
+16,838
+1% +$145K ﹤0.01% 1288
2019
Q2
$12.6M Sell
1,154,044
-1,475,001
-56% -$16.1M ﹤0.01% 1274
2019
Q1
$29.8M Sell
2,629,045
-1,061,830
-29% -$12M ﹤0.01% 1047
2018
Q4
$32M Sell
3,690,875
-6,964,363
-65% -$60.4M 0.01% 982
2018
Q3
$165M Sell
10,655,238
-2,680,060
-20% -$41.4M 0.02% 535
2018
Q2
$214M Sell
13,335,298
-1,243,980
-9% -$19.9M 0.03% 460
2018
Q1
$188M Sell
14,579,278
-6,750,018
-32% -$87.2M 0.03% 472
2017
Q4
$268M Buy
21,329,296
+1,078,471
+5% +$13.5M 0.04% 394
2017
Q3
$267M Buy
20,250,825
+638,103
+3% +$8.43M 0.05% 384
2017
Q2
$310M Buy
19,612,722
+142,710
+0.7% +$2.26M 0.06% 341
2017
Q1
$278M Buy
19,470,012
+2,170,059
+13% +$31M 0.05% 355
2016
Q4
$222M Buy
17,299,953
+6,827,507
+65% +$87.4M 0.04% 405
2016
Q3
$139M Buy
10,472,446
+1,515,556
+17% +$20.2M 0.03% 501
2016
Q2
$98.1M Buy
8,956,890
+950,869
+12% +$10.4M 0.02% 569
2016
Q1
$73.4M Buy
8,006,021
+1,895,117
+31% +$17.4M 0.02% 649
2015
Q4
$59.3M Sell
6,110,904
-13,492
-0.2% -$131K 0.01% 707
2015
Q3
$53.4M Sell
6,124,396
-72,106
-1% -$629K 0.01% 752
2015
Q2
$62.6M Buy
6,196,502
+3,055,986
+97% +$30.9M 0.01% 759
2015
Q1
$42.1M Buy
3,140,516
+1,981,596
+171% +$26.6M 0.01% 893
2014
Q4
$14.9M Sell
1,158,920
-532,621
-31% -$6.83M ﹤0.01% 1216
2014
Q3
$18.4M Sell
1,691,541
-35,820
-2% -$389K ﹤0.01% 1141
2014
Q2
$22.2M Sell
1,727,361
-477,642
-22% -$6.13M ﹤0.01% 1098
2014
Q1
$22.8M Sell
2,205,003
-146,525
-6% -$1.51M 0.01% 1073
2013
Q4
$22.9M Buy
2,351,528
+312,892
+15% +$3.04M 0.01% 1066
2013
Q3
$20.2M Buy
2,038,636
+113,789
+6% +$1.13M 0.01% 1074
2013
Q2
$16M Buy
+1,924,847
New +$16M ﹤0.01% 1132